Menopause
Feature
USPSTF discourages postmenopausal hormone therapy for prevention
The recommendations do not apply to women using hormone therapy to manage their menopause symptoms.
Conference Coverage
Endometrial cancer rates increased following WHI
SAN DIEGO – Endometrial cancer rates spiked between 2006 and 2014, according to a large analysis of national data.
From the Journals
Updated osteoporosis guideline advocates bisphosphonates, nixes estrogens
Even though well-designed, randomized controlled trials amply demonstrate the effectiveness of bisphosphonates in preventing fractures,...
News
FDA approves abaloparatide for postmenopausal osteoporosis
The Food and Drug Administration has approved abaloparatide (Tymlos) for postmenopausal women with osteoporosis at high risk for fracture.
Conference Coverage
Postmenopausal hot flashes cut by 93% with novel nonhormonal treatment
The investigational neurokinin 3 receptor antagonist fezolinetant successfully and safely reduced hot flushes in postmenopausal women.
From the Journals
Study shows no adverse events with long-term denosumab in postmenopausal women
Denosumab, taken long term, is not linked with any adverse events, an analysis of the participants in the FREEDOM trial showed.
Conference Coverage
Neurokinin receptor antagonist nearly halves hot flashes
ORLANDO – The novel approach reduced hot flashes without the need for estrogen in a phase II trial.
Conference Coverage
Bioidentical hormone replacement fares well in phase III trial
ORLANDO – Phase III trial results represent another step toward FDA approval of a formulation of bioidentical hormone therapy to treat hot flashes...
Conference Coverage
HT use associated with lower postmenopausal coronary artery calcium scores
Could the lower postmenopausal coronary artery calcium scores seen in HT users be linked to lower all-cause mortality?
News from the FDA/CDC
FDA approves vaginal insert to treat dyspareunia in menopause
It’s the first FDA-approved product containing the active ingredient prasterone, known also as DHEA. It will be marketed by Endoceutics Inc., a...
Feature
It’s not easy to identify clinical depression in menopause
Clinical depression isn’t a more severe extreme of milder depressive symptoms, but rather a distinct clinical entity, said Hadine Joffe, MD, and...